Andrés Rodríguez Parra, MD (@rodriguezparra_) 's Twitter Profile
Andrés Rodríguez Parra, MD

@rodriguezparra_

Digestive Surgeon and Bariatric Endoscopist @UNAM_mx @HospitalGeaMx LATAM 🇪🇨 🏥@HSantaInes

ID: 223042280

linkhttps://www.linkedin.com/in/andr%C3%A9s-rodr%C3%ADguez-parra-md-5620aa162 calendar_today05-12-2010 06:12:10

13,13K Tweet

4,4K Followers

2,2K Following

Barham Abu Dayyeh MD MPH FASGE FAGA FAFS (@babudayyeh) 's Twitter Profile Photo

🔄 Next-Gen ESG in Action! interlocking endoscopic sleeve gastroplasty iESG. Value added to the procedure and technique with enhanced outcomes, durability, and efficiency. Watch the video videogie.org/article/S2468-… #Endoscopy #GITwitter #ObesityCare #Innovation #ESG

Pichamol Jirapinyo, MD, MPH (@sighpichamol) 's Twitter Profile Photo

Wonderful kickoff session at #FES2025 by expert faculty! Hiroyuki Aihara, MD, PhD on ESD Neil Sharma, M.D. FASGE, FACG, AGAF on G/Z-POEM Austin Chiang, MD MPH FASGE FACG on AI Tolga Erim, DO on electrosurgical waveforms #Inoue on GERD #Stavropoulos on POEM #Kansevoy on device-assited ESD Off to an inspiring start!

Wonderful kickoff session at #FES2025 by expert faculty! 
<a href="/ThirdspaceEndo/">Hiroyuki Aihara, MD, PhD</a> on ESD
<a href="/neilRsharmaMD/">Neil Sharma, M.D. FASGE, FACG, AGAF</a> on G/Z-POEM
<a href="/AustinChiangMD/">Austin Chiang, MD MPH FASGE FACG</a> on AI
<a href="/TolgaErim/">Tolga Erim, DO</a> on electrosurgical waveforms
#Inoue on GERD
#Stavropoulos on POEM
#Kansevoy on device-assited ESD
Off to an inspiring start!
Daniel Calle Rodas (@drdanielcaller) 's Twitter Profile Photo

COLITIS ULCERATIVA ACG 2025 Qué lo siento como básico en nuestro medio ➡️ Descartar clostridiodes al diagnóstico ➡️ Bx de áreas afectadas y no afectadas Monitorización: ☢️ US intestinal: actividad - engrosamiento de la mucosa. #IBD #ulcerativecolitis

COLITIS ULCERATIVA ACG 2025
Qué lo siento como básico en nuestro medio 

➡️ Descartar clostridiodes al diagnóstico
➡️ Bx de áreas afectadas y no afectadas

Monitorización:
☢️ US intestinal: actividad - engrosamiento de la mucosa.

#IBD #ulcerativecolitis
Gavin Preston, M.D. (@gavinprestonmd) 's Twitter Profile Photo

The only appropriate role for a health insurance company is to pay bills, not to "manage" care. The only appropriate decision-makers in health care are patients and their doctors.

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🚨 GLP-1s vs Surgery: Who Wins Long Term? - - - A new 2-year comparative study from NYU Langone just dropped—and the results are clear: 📊 Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide): 🔹 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat)

🚨 GLP-1s vs Surgery: Who Wins Long Term?
- - -
A new 2-year comparative study from NYU Langone just dropped—and the results are clear:

📊 Bariatric Surgery vs GLP-1s (semaglutide/tirzepatide):
🔹 25.7% total body weight loss with surgery vs 5.3% with GLP-1s (intention-to-treat)
Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

🧠 Tirzepatide doesn’t just reduce appetite—it rewires the brain. - - - A new Nature Medicine Phase 1 RCT (n=114) explored how tirzepatide changes eating behavior—and the brain’s response to food—in people with overweight or obesity. 📉 Key Findings at 3–6 Weeks 🔹-524 kcal/day

🧠 Tirzepatide doesn’t just reduce appetite—it rewires the brain.
- - -
A new Nature Medicine Phase 1 RCT (n=114) explored how tirzepatide changes eating behavior—and the brain’s response to food—in people with overweight or obesity.

📉 Key Findings at 3–6 Weeks
🔹-524 kcal/day
Andrés Rodríguez Parra, MD (@rodriguezparra_) 's Twitter Profile Photo

Se juzga si tienen obesidad y si quieren bajar de peso. Se da un comentario sin tener ningún tipo de conocimiento de medicina. No importa lo que utilice, la obesidad es una enfermedad y debe controlarse. Que Ibai sirva de ejemplo para lograr un cambio de peso.

Pichamol Jirapinyo, MD, MPH (@sighpichamol) 's Twitter Profile Photo

One of the most common questions asked by our patients and referring MDs: does endoscopic gastric remodeling (EGR) worsen acid reflux? Our study showed the opposite! EGR is associated with improved reflux symptoms and reduced PPI use. #Obesity #GERD shorturl.at/bEjEJ

One of the most common questions asked by our patients and referring MDs: does endoscopic gastric remodeling (EGR) worsen acid reflux?

Our study showed the opposite! EGR is associated with improved reflux symptoms and reduced PPI use. #Obesity #GERD

shorturl.at/bEjEJ
Barham Abu Dayyeh MD MPH FASGE FAGA FAFS (@babudayyeh) 's Twitter Profile Photo

Our group was the first to define POSED (Post-Obesity Surgery Esophageal Dysfunction), a newly recognized motility disorder that can develop in a subset of patients after metabolic bariatric surgery. In our latest Neurogastro & Motil Neurogastroenterology & Motility study, we uncover a

Our group was the first to define POSED (Post-Obesity Surgery Esophageal Dysfunction), a newly recognized motility disorder that can develop in a subset of patients after metabolic bariatric surgery.

In our latest <a href="/NGMJournal/">Neurogastro & Motil</a> Neurogastroenterology &amp; Motility study, we uncover a
Hassan Siddiki MD, MS (@siddikigi) 's Twitter Profile Photo

What is everyone’s preference when it comes to pre-cut for a CBD stone in lower CBD ? A video showing landmarks for pre-cut and extension after pre-cut.

Barham Abu Dayyeh MD MPH FASGE FAGA FAFS (@babudayyeh) 's Twitter Profile Photo

Gut-Based Therapeutics: Redefining the Continuum of Metabolic Care Endoscopic Sleeve Gastroplasty (#ESG) exemplifies a growing class of gut-based endoscopic interventions with the potential to reshape the metabolic disease treatment paradigm. Positioned between pharmacotherapy

Gut-Based Therapeutics: Redefining the Continuum of Metabolic Care

Endoscopic Sleeve Gastroplasty (#ESG) exemplifies a growing class of gut-based endoscopic interventions with the potential to reshape the metabolic disease treatment paradigm. Positioned between pharmacotherapy
GIE (@gie_journal) 's Twitter Profile Photo

New on the Endoscopedia blog: "Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study" by Ali Lahooti and Reem Z. Sharaiha endoscopedia.com/2025/07/09/lah… Ali Lahooti MD Reem Sharaiha, MD MS

New on the Endoscopedia blog: "Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort study" by Ali Lahooti and Reem Z. Sharaiha endoscopedia.com/2025/07/09/lah…

<a href="/Ali_LahootiMD/">Ali Lahooti MD</a> <a href="/ReemSharaiha/">Reem Sharaiha, MD MS</a>
Oscar Tahuahua (@oscartahuahua) 's Twitter Profile Photo

Estudio global con 2.07M en NEJM de adultos en 39 países. ✅La ausencia de 5 factores de riesgo a los 50 años (HAS, dislipidemia, IMC anormal, DM2 & tabaquismo) se asoció con +13.3 años libres de ECV y +14.5 años de sobrevida en mujeres; +10.6 y +11.8 en hombres. 1/3👇

Estudio global con 2.07M en <a href="/NEJM/">NEJM</a> de adultos en 39 países. 

✅La ausencia de 5 factores de riesgo a los 50 años (HAS, dislipidemia, IMC anormal, DM2 &amp; tabaquismo) se asoció con +13.3 años libres de ECV y +14.5 años de sobrevida en mujeres; +10.6 y +11.8 en hombres. 1/3👇
Jan Král (@kraljan) 's Twitter Profile Photo

🚨Monthly anti-obesity injection? 💉 💡 A new phase 2 trial in NEJM tests maridebart cafraglutide (MariTide) — a GLP-1 agonist & GIP antagonist combo 🔬 showing promise for long-interval #obesity therapy 💪🏽 🔗 tinyurl.com/3y2y32vh #GITwitter #MedTwitter NEJM my_UEG

🚨Monthly anti-obesity injection? 💉

💡 A new phase 2 trial in NEJM tests maridebart cafraglutide (MariTide) — a GLP-1 agonist &amp; GIP antagonist combo 🔬 showing promise for long-interval #obesity therapy 💪🏽

🔗 tinyurl.com/3y2y32vh

#GITwitter #MedTwitter 
<a href="/NEJM/">NEJM</a> <a href="/my_ueg/">my_UEG</a>
Jan Král (@kraljan) 's Twitter Profile Photo

🚨 A new #obesity definition is here! 🚨 EASO’s framework uses #BMI 📏 + waist ratio 📐 + comorbidities 🩺 to redefine risk. Now tested on 44,030 adults in NHANES 🇺🇸 (1999–2018). Game-changer for obesity care? 🔍 🔗 tinyurl.com/2xzw83jp #MedTwitter #Endocrine #GITwitter

🚨 A new #obesity definition is here! 🚨

EASO’s framework uses #BMI 📏 + waist ratio 📐 + comorbidities 🩺 to redefine risk. Now tested on 44,030 adults in NHANES 🇺🇸 (1999–2018). 

Game-changer for obesity care? 🔍
🔗 tinyurl.com/2xzw83jp 

#MedTwitter #Endocrine #GITwitter
Andy Tau, MD (@drbloodandguts) 's Twitter Profile Photo

Here is a gastric ulcer with an adherent clot. I always inject epi prior to snaring clot. I like to snare with same technique as polyp. Note: The cross section of this vessel has a thick white fibrin plug. I have learned over the years that not all clots are equal. This one